Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Growth Hormone in Amyotrophic Lateral Sclerosis

This study has been completed.
Istituto Biostrutture e Immagini, CNR Naples
Agenzia Italiana del Farmaco
Information provided by:
Federico II University Identifier:
First received: March 3, 2008
Last updated: May 25, 2010
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)